Creatinine | sciencenewsnet.in

Breaking News

At the Roots of Business Ethics: A New Reading of the Merchant of Venice

Digital Science Teams Up with Huron to Strengthen Research Security and Compliance for Education and Research Clients

American Thyroid Association® Announces 2024-2025 Officers and Board of Directors

Diabetes Drug Appears to Fight Lung Cancer — But Only in Overweight or Obese Patients

Don’t Rock the Boat: The Social-symbolic Work to Confront Ethnic Discrimination in Branches of Professional Service Firms

Virtual replicas for real-world solutions: digital twins in action

Beyond lithium: the rise of sustainable battery alternatives

Novel Gene Therapy Trial for Sickle Cell Disease Launches

Behind the Model: Science Inspired by Legos

Quantifying disease impact and overcoming practical treatment barriers for primary progressive aphasia

26 Nov, 2024

Second Heart Assist Announces an Impressive Successful Completion of a First-In-Human Case Study in Central America with its Whisper™ Device

July 25, 2024 sarah JonasAnnouncement

Utah-based Second Heart Assist Inc., announced today the successful completion of the company’s first Central American case to evaluate the performance of its Whisper™ percutaneous mechanical circulatory device, designed to improve both cardiac function and renal perfusion in patients hospitalized with acute decompensated heart failure (ADHF). Second Heart Assist has already successfully performed FIH studies in Panama (South America) and other OUS countries for multiple indications.